Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Cancer Cell
|
July 13, 2013
BCL-2: a new therapeutic target in estrogen receptor-positive breast cancer?
Lesley-Ann Martin, Mitch Dowsett
International Journal of Cancer
|
January 3, 2013
Biomarkers for the clinical management of breast cancer: international perspective
Neill Patani, Lesley-Ann Martin, Mitch Dowsett
Clinical Breast Cancer
|
December 1, 2010
Targeting endocrine resistance: is there a role for mTOR inhibition?
Amna Sheri, Lesley-Ann Martin, Stephen Johnston
Breast Cancer Research and Treatment
|
October 26, 2005
Life following aromatase inhibitors--where now for endocrine sequencing?
Stephen R Johnston, Lesley-Ann Martin, Mitch Dowsett
Molecular and Cellular Endocrinology
|
January 25, 2011
New and translational perspectives of oestrogen deprivation in breast cancer
Anita K Dunbier, Lesley-Ann Martin, Mitch Dowsett
Nature Clinical Practice. Oncology
|
August 31, 2007
Mechanisms of disease: angiogenesis and the management of breast cancer
Susana Banerjee, Mitch Dowsett, Alan Ashworth, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
June 29, 2005
Mechanisms of resistance to aromatase inhibitors
Mitch Dowsett, Lesley-Ann Martin, Ian Smith, et al.
STAR Protocols
|
January 11, 2025
Protocol to identify endogenous proximal proteins using biotinylation by antibody recognition
Camilla Rega, Mercedes Pardo, Lesley-Ann Martin, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
October 20, 2006
The relationship between factors affecting endogenous oestradiol levels in postmenopausal women and breast cancer
Elizabeth J Folkerd, Lesley-Ann Martin, Anne Kendall, et al.
Breast Cancer Research and Treatment
|
September 9, 2011
The role of caveolin-1 in human breast cancer
Neill Patani, Lesley-Ann Martin, Jorge S Reis-Filho, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Cancer Cell
|
July 13, 2013
BCL-2: a new therapeutic target in estrogen receptor-positive breast cancer?
Lesley-Ann Martin, Mitch Dowsett
International Journal of Cancer
|
January 3, 2013
Biomarkers for the clinical management of breast cancer: international perspective
Neill Patani, Lesley-Ann Martin, Mitch Dowsett
Clinical Breast Cancer
|
December 1, 2010
Targeting endocrine resistance: is there a role for mTOR inhibition?
Amna Sheri, Lesley-Ann Martin, Stephen Johnston
Breast Cancer Research and Treatment
|
October 26, 2005
Life following aromatase inhibitors--where now for endocrine sequencing?
Stephen R Johnston, Lesley-Ann Martin, Mitch Dowsett
Molecular and Cellular Endocrinology
|
January 25, 2011
New and translational perspectives of oestrogen deprivation in breast cancer
Anita K Dunbier, Lesley-Ann Martin, Mitch Dowsett
Nature Clinical Practice. Oncology
|
August 31, 2007
Mechanisms of disease: angiogenesis and the management of breast cancer
Susana Banerjee, Mitch Dowsett, Alan Ashworth, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
June 29, 2005
Mechanisms of resistance to aromatase inhibitors
Mitch Dowsett, Lesley-Ann Martin, Ian Smith, et al.
STAR Protocols
|
January 11, 2025
Protocol to identify endogenous proximal proteins using biotinylation by antibody recognition
Camilla Rega, Mercedes Pardo, Lesley-Ann Martin, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
October 20, 2006
The relationship between factors affecting endogenous oestradiol levels in postmenopausal women and breast cancer
Elizabeth J Folkerd, Lesley-Ann Martin, Anne Kendall, et al.
Breast Cancer Research and Treatment
|
September 9, 2011
The role of caveolin-1 in human breast cancer
Neill Patani, Lesley-Ann Martin, Jorge S Reis-Filho, et al.
Page
of 8